Understanding the pathophysiologic pathways that underlie obesity and options for treatment

References

• Tremmel M , Gerdtham UG , Nilsson PM , et al. Economic burden of obesity: a systematic literature review. Int J Environ Res Public Health. 2017;14(4):435.
   PubMed Web of Science ®Google Scholar
• Bray GA , Heisel WE , and Afshin A , et al. The science of obesity management: an Endocrine Society scientific statement. Endocr Rev. 2018;39(2):79–132.
   PubMed Web of Science ®Google Scholar
• Calle EE , Rodriguez C , Walker-Thurmond K , et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625–1638.
   PubMed Web of Science ®Google Scholar
• WHO Expert Consultation . Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–163.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention . Overweight and obesity. 2020 Accessed 30 July 2021. Available from: https://www.cdc.gov/obesity/data/adult.html
   Google Scholar
• Wang YC , McPherson K , Marsh T , et al. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet. 2011;378(9793):815–825.
   PubMed Web of Science ®Google Scholar
• van der Klaauw AA , Farooqi IS. The hunger genes: pathways to obesity. Cell. 2015;161(1):119–132.
   PubMed Web of Science ®Google Scholar
• Ritten A , LaManna J . Unmet needs in obesity management: from guidelines to clinic. J Am Assoc Nurse Pract. 2017;29(S1):S30–S42.
   PubMed Web of Science ®Google Scholar
• Martinez Steele E , Baraldi LG , Louzada ML , et al. Ultra-processed foods and added sugars in the US diet: evidence from a nationally representative cross-sectional study. BMJ Open. 2016;6(3):e009892.
   PubMed Web of Science ®Google Scholar
• Silva Meneguelli T , Viana Hinkelmann J , Hermsdorff HHM , et al. Food consumption by degree of processing and cardiometabolic risk: a systematic review. Int J Food Sci Nutr. 2020;71:678–692.
   PubMed Web of Science ®Google Scholar
• Harvard School of Public Health . Obesity causes. 2019 Accessed 30 July 2021. Available from: https://www.hsph.harvard.edu/obesity-prevention-source/obesity-causes/
   Google Scholar
• Allison DB , Downey M , and Atkinson RL , et al. Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of The Obesity Society. Obesity (Silver Spring). 2008;16(6):1161–1177.
   PubMed Web of Science ®Google Scholar
• Jensen MD , Ryan DH , Apovian CM , et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014;63(25):2985–3023.
   PubMed Web of Science ®Google Scholar
• Apovian CM , Aronne LJ . The 2013 American Heart Association/American College of Cardiology/The Obesity Society guideline for the management of overweight and obesity in adults: what is new about diet, drugs, and surgery for obesity? Circulation. 2015;132(16):1586–1591.
   PubMed Web of Science ®Google Scholar
• Schwartz MW , Seeley RJ , and Zeltser LM , et al. Obesity pathogenesis: an Endocrine Society scientific statement. Endocr Rev. 2017;38(4):267–296.
   PubMed Web of Science ®Google Scholar
• Srivastava G , Apovian CM . Current pharmacotherapy for obesity. Nat Rev Endocrinol. 2018;14(1):12–24.
   PubMed Web of Science ®Google Scholar
• Apovian CM , Aronne LJ , Bessesen DH , et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342–362.
   PubMed Web of Science ®Google Scholar
• Berthoud HR , Munzberg H , Morrison CD , et al. Blaming the brain for obesity: integration of hedonic and homeostatic mechanisms. Gastroenterology. 2017;152(7):1728–1738.
   PubMed Web of Science ®Google Scholar
• Greenway FL . Physiological adaptations to weight loss and factors favouring weight regain. Int J Obes (Lond). 2015;39(8):1188–1196.
   PubMed Web of Science ®Google Scholar
• Oussaada SM , Van Galen KA , and Cooiman MI , et al. The pathogenesis of obesity. Metabolism. 2019;92:26–36.
   PubMed Web of Science ®Google Scholar
• Zoico E , Rubele S , De Caro A , et al. Brown and beige adipose tissue and aging. Front Endocrinol (Lausanne). 2019;10:368.
   PubMed Web of Science ®Google Scholar
• Puar T , van Berkel A , Gotthardt M , et al. Genotype-dependent brown adipose tissue activation in patients with pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2016;101(1):224–232.
   PubMed Web of Science ®Google Scholar
• O’Mara AE , Johnson JW , Linderman JD , et al. Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity. J Clin Invest. 2020;130(5):2209–2219.
   PubMed Web of Science ®Google Scholar
• Gerard P . Gut microbiota and obesity. Cell Mol Life Sci. 2016;73(1):147–162.
   PubMed Web of Science ®Google Scholar
• Chelimo C , Camargo CA Jr. , Morton SMB , et al. Association of repeated antibiotic exposure up to age 4 years with body mass at age 4.5 years. JAMA Network Open. 2020;3(1):e1917577.
   PubMed Web of Science ®Google Scholar
• Baskin KK , Winders BR , Olson EN , et al. Muscle as a “mediator” of systemic metabolism. Cell Metab. 2015;21(2):237–248.
   PubMed Web of Science ®Google Scholar
• DeBenedictis JN , Nymo S , Ollestad KH , et al. Changes in the homeostatic appetite system after weight loss reflect a normalization toward a lower body weight. J Clin Endocrinol Metab. 2020;105(7): e2538–e2546.
   Web of Science ®Google Scholar
• Fothergill E , Guo J , Howard L , et al. Persistent metabolic adaptation 6 years after “The Biggest Loser” competition. Obesity (Silver Spring). 2016;24(8):1612–1619.
   PubMed Web of Science ®Google Scholar
• Gomez-Arbelaez D , Crujeiras AB , Castro AI , et al. Resting metabolic rate of obese patients under very low calorie ketogenic diet. Nutr Metab (Lond). 2018;15(1):18.
   PubMedGoogle Scholar
• Bray MS , Loos RJ , McCaffery JM , et al. NIH working group report-using genomic information to guide weight management: from universal to precision treatment. Obesity (Silver Spring). 2016;24(1):14–22.
   PubMed Web of Science ®Google Scholar
• Heymsfield SB , Wadden TA . Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376(15):1492.
   PubMedGoogle Scholar
• Kalantari N , Doaei S , Keshavarz-Mohammadi N , et al. Review of studies on the fat mass and obesity-associated (FTO) gene interactions with environmental factors affecting on obesity and its impact on lifestyle interventions. ARYA Atheroscler. 2016;12(6):281–290.
   PubMed Web of Science ®Google Scholar
• Herrera BM , Keildson S , Lindgren CM , et al. Genetics and epigenetics of obesity. Maturitas. 2011;69(1):41–49.
   PubMed Web of Science ®Google Scholar
• Sanli E , Kabaran S . Maternal obesity, maternal overnutrition and fetal programming: effects of epigenetic mechanisms on the development of metabolic disorders. Curr Genomics. 2019;20(6):419–427.
   PubMed Web of Science ®Google Scholar
• Rashid CS , Bansal A , Simmons RA , et al. Oxidative stress, intrauterine growth restriction, and developmental programming of type 2 diabetes. Physiology (Bethesda). 2018;33(5):348–359.
   PubMed Web of Science ®Google Scholar
• Beccuti G , Pannain S . Sleep and obesity. Curr Opin Clin Nutr Metab Care. 2011;14(4):402–412.
   PubMed Web of Science ®Google Scholar
• Sanyal D , Raychaudhuri M . Hypothyroidism and obesity: an intriguing link. Indian J Endocrinol Metab. 2016;20(4):554–557.
   PubMedGoogle Scholar
• Gore AC , Chappell VA , Fenton SE , et al. EDC-2: the Endocrine Society’s second scientific statement on endocrine-disrupting chemicals. Endocr Rev. 2015;36(6):E1–E150.
   PubMed Web of Science ®Google Scholar
• Saunders KH , Igel LI , Shukla AP , et al. Drug-induced weight gain: rethinking our choices. J Fam Pract. 2016;65(11):780–788.
   PubMed Web of Science ®Google Scholar
• Garvey WT , Mechanick JI , Brett EM , et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(Suppl 3):1–203.
   PubMed Web of Science ®Google Scholar
• Frühbeck G , Busetto L , Dicker D , et al. The ABCD of Obesity: An EASO Position Statement on a Diagnostic Term with Clinical and Scientific Implications. Obes Facts. 2019;12(2):131–136.
   PubMed Web of Science ®Google Scholar
• Wharton S , Lau DCW , Vallis M , et al. Obesity in adults: a clinical practice guideline. CMAJ. 2020;192(31):E875–E891.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 8 . Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes - 2019. Diabetes Care. 2019;42(Supplement 1):S81–S89.
   PubMedGoogle Scholar
• Look AHEAD Research Group . Eight-year weight losses with an intensive lifestyle intervention: the Look AHEAD study. Obesity (Silver Spring). 2014;22(1):5–13.
   PubMed Web of Science ®Google Scholar
• Look AHEAD Research Group, Pi-Sunyer X , Blackburn G , et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the Look AHEAD trial. Diabetes Care. 2007;30(6):1374–1383.
   PubMed Web of Science ®Google Scholar
• Look AHEAD Research Group, Gregg EW, Jakicic JM, et al. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2016;4(11):913–921.
   PubMedGoogle Scholar
• Diabetes Prevention Program Research Group . The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002;25(12):2165–2171.
   PubMed Web of Science ®Google Scholar
• Diabetes Prevention Program Research Group, Knowler WC , and Fowler SE , et al. 10-Year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program outcomes study. Lancet. 2009;374(9702):1677–1686.
   PubMed Web of Science ®Google Scholar
• Knowler WC , Barrett-Connor E , Fowler SE , et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.
   PubMed Web of Science ®Google Scholar
• Bays HE , McCarthy W , Christensen S , et al. Obesity algorithm® 2020 eBook. 2000 [cited 2020 Jul 23]. Available from: https://obesitymedicine.org/obesity-algorithm/
   Google Scholar
• Khera R , Murad MH , Chandar AK , et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA. 2016;315(22):2424–2434.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration . FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market. 2020 Accessed 30 July 2021. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-requests-withdrawal-weight-loss-drug-belviq-belviq-xr-lorcaserin-market
   Google Scholar
• Wilding JPH , Batterham RL , and Calanna S , et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989.
   PubMed Web of Science ®Google Scholar
• Wadden TA , Bailey TS , Billings LK , et al. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial. JAMA. 2021;325(14):1403–1413.
   PubMed Web of Science ®Google Scholar
• Davies M , Faerch L , Jeppesen OK , et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021;397(10278):971–984.
   PubMed Web of Science ®Google Scholar
• Yanovski SZ , Yanovski JA . Long-term drug treatment for obesity: a systematic and clinical review. JAMA. 2014;311(1):74–86.
   PubMed Web of Science ®Google Scholar
• Gadde KM , Allison DB , Ryan DH , et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet. 2011;377(9774):1341–1352.
   PubMed Web of Science ®Google Scholar
• Pi-Sunyer X , Astrup A , Fujioka K , et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015;373(1):11–22.
   PubMed Web of Science ®Google Scholar
• Torgerson JS , Hauptman J , Boldrin MN , et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27(1):155–161.
   PubMed Web of Science ®Google Scholar
• Guo F , Garvey WT . Cardiometabolic disease staging predicts effectiveness of weight-loss therapy to prevent type 2 diabetes: pooled results from phase III clinical trials assessing phentermine/topiramate extended release. Diabetes Care. 2017;40(7):856–862.
   PubMed Web of Science ®Google Scholar
• le Roux CW , Astrup A , Fujioka K , et al. 3 Years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet. 2017;389(10077):1399–1409.
   PubMed Web of Science ®Google Scholar
• Oh TJ . The role of anti-obesity medication in prevention of diabetes and its complications. J Obes Metab Syndr. 2019;28(3):158–166.
   PubMed Web of Science ®Google Scholar
• Bays HE , McCarthy W , Burridge K , et al. Adult Obesity Algorithm eBook: Detailed overview of Obesity Medicine. 2021 [ cited 2021 September 14]. Available from: https://obesitymedicine.org/obesity-algorithm/
   Google Scholar
• Arterburn D , Wellman R , Emiliano A , et al. Comparative Effectiveness and Safety of Bariatric Procedures for Weight Loss: A PCORnet Cohort Study. Ann Intern Med. 2018;169(11):741–750.
   PubMed Web of Science ®Google Scholar
• Topart P , Becouarn G , Delarue J. Weight Loss and Nutritional Outcomes 10 Years after Biliopancreatic Diversion with Duodenal Switch. Obes Surg. 2017;27(7):1645–1650.
   PubMed Web of Science ®Google Scholar
• Marinari GM , Papadia FS , Briatore L , et al. Type 2 diabetes and weight loss following biliopancreatic diversion for obesity. Obes Surg. 2006;16(11):1440–1444.
   PubMed Web of Science ®Google Scholar
• Cottam D , Roslin M , Enochs P , et al. Single Anastomosis Duodenal Switch: 1-Year Outcomes. Obes Surg. 2020;30(4):1506–1514.
   PubMed Web of Science ®Google Scholar
• Pucci A , Batterham RL . Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet different. J Endocrinol Invest. 2019;42(2):117–128.
   PubMed Web of Science ®Google Scholar
• Sjöström L , Narbro K , Sjöström CD , et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–752.
   PubMed Web of Science ®Google Scholar
• Adams TD , Gress RE , Smith SC , et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–761.
   PubMed Web of Science ®Google Scholar
• Purnell JQ , Selzer F , and Wahed AS , et al. Type 2 diabetes remission rates after laparoscopic gastric bypass and gastric banding: results of the Longitudinal Assessment of Bariatric Surgery study. Diabetes Care. 2016;39(7):1101–1107.
   PubMed Web of Science ®Google Scholar
• Courcoulas AP , King WC , and Belle SH , et al. Seven-year weight trajectories and health outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) study. JAMA Surg. 2018;153(5):427–434.
   PubMed Web of Science ®Google Scholar
• Schauer PR , Bhatt DL , Kirwan JP , et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. 2017;376(7):641–651.
   PubMed Web of Science ®Google Scholar
• Purnell JQ , Dewey EN , Laferrère B , et al. Diabetes remission status during seven-year follow-up of the Longitudinal Assessment of Bariatric Surgery study. J Clin Endocrinol Metab. 2021;106(3):774–788.
   PubMed Web of Science ®Google Scholar
• Vinzens F , Kilchenmann A , and Zumstein V , et al. Long-term outcome of laparoscopic adjustable gastric banding (LAGB): results of a Swiss single-center study of 405 patients with up to 18 years’ follow-up. Surg Obes Relat Dis. 2017;13(8):1313–1319.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention . Attempts to lose weight among adults in the United States, 2013–2016. 2018 Accessed 30 July 2021. Available from: https://www.cdc.gov/nchs/data/databriefs/db313.pdf
   Google Scholar
• Wing RR , Phelan S . Long-term weight loss maintenance. Am J Clin Nutr. 2005;82(1):222S–225S.
   PubMed Web of Science ®Google Scholar
• Anderson JW , Konz EC , Frederich RC , et al. Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr. 2001;74(5):579–584.
   PubMed Web of Science ®Google Scholar
• Kraschnewski JL , Boan J , Esposito J , et al. Long-term weight loss maintenance in the United States. Int J Obes (Lond). 2010;34(11):1644–1654.
   PubMed Web of Science ®Google Scholar
• Vallis M , Piccinini-Vallis H , and Sharma AM , et al. Clinical review: modified 5 As: minimal intervention for obesity counseling in primary care. Can Fam Physician. 2013;59(1):27–31.
   PubMed Web of Science ®Google Scholar